These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
473 related items for PubMed ID: 20458084
1. Proton pump inhibitors and risk for recurrent Clostridium difficile infection. Linsky A, Gupta K, Lawler EV, Fonda JR, Hermos JA. Arch Intern Med; 2010 May 10; 170(9):772-8. PubMed ID: 20458084 [Abstract] [Full Text] [Related]
9. Incidence of Clostridium difficile infection in patients receiving high-risk antibiotics with or without a proton pump inhibitor. Gordon D, Young LR, Reddy S, Bergman C, Young JD. J Hosp Infect; 2016 Feb 15; 92(2):173-7. PubMed ID: 26616410 [Abstract] [Full Text] [Related]
10. Association between proton pump inhibitor therapy and Clostridium difficile infection in a meta-analysis. Deshpande A, Pant C, Pasupuleti V, Rolston DD, Jain A, Deshpande N, Thota P, Sferra TJ, Hernandez AV. Clin Gastroenterol Hepatol; 2012 Mar 15; 10(3):225-33. PubMed ID: 22019794 [Abstract] [Full Text] [Related]
11. Proton Pump Inhibitors and the Risk for Hospital-Acquired Clostridium difficile Infection. Barletta JF, El-Ibiary SY, Davis LE, Nguyen B, Raney CR. Mayo Clin Proc; 2013 Oct 15; 88(10):1085-90. PubMed ID: 24012413 [Abstract] [Full Text] [Related]
12. Gastric acid suppression by proton pump inhibitors as a risk factor for clostridium difficile-associated diarrhea in hospitalized patients. Aseeri M, Schroeder T, Kramer J, Zackula R. Am J Gastroenterol; 2008 Sep 15; 103(9):2308-13. PubMed ID: 18702653 [Abstract] [Full Text] [Related]
13. Risk of Clostridium difficile Infection with the Use of a Proton Pump Inhibitor for Stress Ulcer Prophylaxis in Critically Ill Patients. Ro Y, Eun CS, Kim HS, Kim JY, Byun YJ, Yoo KS, Han DS. Gut Liver; 2016 Jul 15; 10(4):581-6. PubMed ID: 27021503 [Abstract] [Full Text] [Related]
15. Effects of proton pump inhibitor use on risk of Clostridium difficile infection: a hospital cohort study. Park YH, Seong JM, Cho S, Han HW, Kim JY, An SH, Gwak HS. J Gastroenterol; 2019 Dec 15; 54(12):1052-1060. PubMed ID: 31187275 [Abstract] [Full Text] [Related]
16. Proton Pump Inhibitors Do Not Increase Risk for Clostridium difficile Infection in the Intensive Care Unit. Faleck DM, Salmasian H, Furuya EY, Larson EL, Abrams JA, Freedberg DE. Am J Gastroenterol; 2016 Nov 15; 111(11):1641-1648. PubMed ID: 27575714 [Abstract] [Full Text] [Related]
17. Comparative risk of Clostridium difficile infection between proton pump inhibitors and histamine-2 receptor antagonists: A 15-year hospital cohort study using a common data model. Seo SI, You SC, Park CH, Kim TJ, Ko YS, Kim Y, Yoo JJ, Kim J, Shin WG. J Gastroenterol Hepatol; 2020 Aug 15; 35(8):1325-1330. PubMed ID: 31970824 [Abstract] [Full Text] [Related]
18. Fluoroquinolone use and risk factors for Clostridium difficile-associated disease within a Veterans Administration health care system. McFarland LV, Clarridge JE, Beneda HW, Raugi GJ. Clin Infect Dis; 2007 Nov 01; 45(9):1141-51. PubMed ID: 17918075 [Abstract] [Full Text] [Related]
19. Cumulative antibiotic exposures over time and the risk of Clostridium difficile infection. Stevens V, Dumyati G, Fine LS, Fisher SG, van Wijngaarden E. Clin Infect Dis; 2011 Jul 01; 53(1):42-8. PubMed ID: 21653301 [Abstract] [Full Text] [Related]
20. Risk of community-acquired pneumonia in veteran patients to whom proton pump inhibitors were dispensed. Hermos JA, Young MM, Fonda JR, Gagnon DR, Fiore LD, Lawler EV. Clin Infect Dis; 2012 Jan 01; 54(1):33-42. PubMed ID: 22100573 [Abstract] [Full Text] [Related] Page: [Next] [New Search]